One week this summer, the Nasdaq stock market listed five recent initial public offerings, including Sonos, the home-audio company, and Vaccinex, which makes a promising cancer drug. That same week, an investor looking at Nasdaq’s Listing Center would have seen the names of 16 stocks set to disappear. The reasons for the delistings varied. Synchronoss Technologies, a software company, had failed to file financial reports since February 2017. Abaxis, a veterinary-diagnostics firm, was being acquired by Zoetis. Capella Education was merging with Strayer Education (both operate for-profit schools).
Image: TYLER COMRIE - https://www.theatlantic.com
